90 related articles for article (PubMed ID: 17075867)
1. Development and validation of a preclinical food effect model.
Lentz KA; Quitko M; Morgan DG; Grace JE; Gleason C; Marathe PH
J Pharm Sci; 2007 Feb; 96(2):459-72. PubMed ID: 17075867
[TBL] [Abstract][Full Text] [Related]
2. Use of the pentagastrin dog model to explore the food effects on formulations in early drug development.
Zane P; Guo Z; MacGerorge D; Vicat P; Ollier C
Eur J Pharm Sci; 2014 Jun; 57():207-13. PubMed ID: 24090732
[TBL] [Abstract][Full Text] [Related]
3. Development of a canine model to enable the preclinical assessment of pH-dependent absorption of test compounds.
Fancher RM; Zhang H; Sleczka B; Derbin G; Rockar R; Marathe P
J Pharm Sci; 2011 Jul; 100(7):2979-88. PubMed ID: 21254068
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the use of Göttingen minipigs to predict food effects on the oral absorption of drugs in humans.
Christiansen ML; Müllertz A; Garmer M; Kristensen J; Jacobsen J; Abrahamsson B; Holm R
J Pharm Sci; 2015 Jan; 104(1):135-43. PubMed ID: 25417837
[TBL] [Abstract][Full Text] [Related]
5. The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human.
Wu Y; Loper A; Landis E; Hettrick L; Novak L; Lynn K; Chen C; Thompson K; Higgins R; Batra U; Shelukar S; Kwei G; Storey D
Int J Pharm; 2004 Nov; 285(1-2):135-46. PubMed ID: 15488686
[TBL] [Abstract][Full Text] [Related]
6. Oral formulations of adefovir dipivoxil: in vitro dissolution and in vivo bioavailability in dogs.
Cundy KC; Sue IL; Visor GC; Marshburn J; Nakamura C; Lee WA; Shaw JP
J Pharm Sci; 1997 Dec; 86(12):1334-8. PubMed ID: 9423141
[TBL] [Abstract][Full Text] [Related]
7. Cinnarizine food-effects in beagle dogs can be avoided by administration in a Self Nano Emulsifying Drug Delivery System (SNEDDS).
Christiansen ML; Holm R; Kristensen J; Kreilgaard M; Jacobsen J; Abrahamsson B; Müllertz A
Eur J Pharm Sci; 2014 Jun; 57():164-72. PubMed ID: 24239996
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
[TBL] [Abstract][Full Text] [Related]
9. Effect of food on the pharmacokinetics of rosuvastatin after administration of a single oral dose in dogs.
Baek IH; Kwon KI; Kim MS
Drug Res (Stuttg); 2013 Mar; 63(3):145-9. PubMed ID: 23447089
[TBL] [Abstract][Full Text] [Related]
10. Impact of food and the proton pump inhibitor rabeprazole on the pharmacokinetics of GDC-0941 in healthy volunteers: bench to bedside investigation of pH-dependent solubility.
Ware JA; Dalziel G; Jin JY; Pellett JD; Smelick GS; West DA; Salphati L; Ding X; Sutton R; Fridyland J; Dresser MJ; Morrisson G; Holden SN
Mol Pharm; 2013 Nov; 10(11):4074-81. PubMed ID: 24099279
[TBL] [Abstract][Full Text] [Related]
11. Effects of food intake on the pharmacokinetic properties of dalcetrapib: findings from three phase I, single-dose crossover studies in healthy volunteers.
Derks M; Kawamura H; Abt M; Meneses-Lorente G; Phelan M; Ishikawa T
Clin Ther; 2011 Jun; 33(6):754-65. PubMed ID: 21704240
[TBL] [Abstract][Full Text] [Related]
12. Fed and fasted state gastro-intestinal in vitro lipolysis: In vitro in vivo relations of a conventional tablet, a SNEDDS and a solidified SNEDDS.
Christophersen PC; Christiansen ML; Holm R; Kristensen J; Jacobsen J; Abrahamsson B; Müllertz A
Eur J Pharm Sci; 2014 Jun; 57():232-9. PubMed ID: 24056027
[TBL] [Abstract][Full Text] [Related]
13. Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin.
Mazzu AL; Lasseter KC; Shamblen EC; Agarwal V; Lettieri J; Sundaresen P
Clin Pharmacol Ther; 2000 Oct; 68(4):391-400. PubMed ID: 11061579
[TBL] [Abstract][Full Text] [Related]
14. Limited sampling strategies for the estimation of atazanavir daily exposure in HIV-infected patients.
Cattaneo D; Ripamonti D; Baldelli S; Cozzi V; Fucile S; Clementi E
Fundam Clin Pharmacol; 2013 Apr; 27(2):216-22. PubMed ID: 22044510
[TBL] [Abstract][Full Text] [Related]
15. Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state.
Arndt M; Chokshi H; Tang K; Parrott NJ; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2013 Aug; 84(3):633-41. PubMed ID: 23434923
[TBL] [Abstract][Full Text] [Related]
16. Re: Acknowledgement of human bioequivalency of matrix's lopinavir-ritonavir formulation to Kaletra, comment to article on Bioavailability of generic ritonavir and lopinavir/ritonavir tablet products in a dog model, by Garren et al.
Rackley RJ
J Pharm Sci; 2010 Feb; 99(2):568-71; author reply 574. PubMed ID: 19746411
[No Abstract] [Full Text] [Related]
17. Effect of food on the oral bioavailability of didanosine from encapsulated enteric-coated beads.
Damle BD; Yan JH; Behr D; O'Mara E; Nichola P; Kaul S; Knupp C
J Clin Pharmacol; 2002 Apr; 42(4):419-27. PubMed ID: 11936567
[TBL] [Abstract][Full Text] [Related]
18. Precipitation in the small intestine may play a more important role in the in vivo performance of poorly soluble weak bases in the fasted state: case example nelfinavir.
Shono Y; Jantratid E; Dressman JB
Eur J Pharm Biopharm; 2011 Oct; 79(2):349-56. PubMed ID: 21527341
[TBL] [Abstract][Full Text] [Related]
19. The effect of food on the absorption of oral ziprasidone.
Miceli JJ; Glue P; Alderman J; Wilner K
Psychopharmacol Bull; 2007; 40(3):58-68. PubMed ID: 18007569
[TBL] [Abstract][Full Text] [Related]
20. Using absorption simulation and gastric pH modulated dog model for formulation development to overcome achlorhydria effect.
Mitra A; Kesisoglou F; Beauchamp M; Zhu W; Chiti F; Wu Y
Mol Pharm; 2011 Dec; 8(6):2216-23. PubMed ID: 21981752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
